Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Rafał Krygier"'
Publikováno v:
International Journal of Occupational Medicine and Environmental Health, Vol 34, Iss 2, Pp 203-209 (2021)
Objectives Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome virus 2 (SARS-CoV-2) had spread worldwide since December 2019 and became a pandemic in March 2020. The diagnosis of an active infection is based on the real-ti
Externí odkaz:
https://doaj.org/article/7890f29230f148158c5b402caa9bd07b
Autor:
Olga Tronina, Michał Brzdęk, Dorota Zarębska-Michaluk, Dorota Dybowska, Beata Lorenc, Ewa Janczewska, Włodzimierz Mazur, Anna Parfieniuk-Kowerda, Anna Piekarska, Rafał Krygier, Jakub Klapaczyński, Hanna Berak, Jerzy Jaroszewicz, Aleksander Garlicki, Krzysztof Tomasiewicz, Jolanta Citko, Robert Flisiak
Publikováno v:
Viruses, Vol 15, Iss 3, p 677 (2023)
Direct-acting antivirals (DAA) regimens have provided hope for eliminating hepatitis C virus (HCV) infection. Patients following ineffective therapy with DAA, especially those previously treated with inhibitors of non-structural protein 5A (NS5A), re
Externí odkaz:
https://doaj.org/article/f76918a6d9b84ca3a68b0e5269e09f90
Autor:
Paweł Rajewski, Dorota Zarębska-Michaluk, Ewa Janczewska, Andrzej Gietka, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Teresa Belica-Wdowik, Barbara Baka-Ćwierz, Dorota Dybowska, Waldemar Halota, Beata Lorenc, Marek Sitko, Aleksander Garlicki, Hanna Berak, Andrzej Horban, Iwona Orłowska, Krzysztof Simon, Łukasz Socha, Marta Wawrzynowicz-Syczewska, Jerzy Jaroszewicz, Zbigniew Deroń, Agnieszka Czauż-Andrzejuk, Jolanta Citko, Rafał Krygier, Anna Piekarska, Łukasz Laurans, Witold Dobracki, Jolanta Białkowska, Olga Tronina, Magdalena Wietlicka-Piszcz, Małgorzata Pawłowska, Robert Flisiak
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 17, p 5193 (2022)
Hepatitis C infection is one of the main reasons for liver cirrhosis and hepatocellular carcinoma. In recent years, more and more is being heard about extrahepatic manifestations of the hepatitis C infection including its possible influence on the de
Externí odkaz:
https://doaj.org/article/fa4304861a654362931223a36429ee57
Autor:
Dorota Zarębska-Michaluk, Anna Piekarska, Jerzy Jaroszewicz, Jakub Klapaczyński, Marek Sitko, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Teresa Belica-Wdowik, Paweł Pabjan, Beata Lorenc, Agnieszka Czauż-Andrzejuk, Olga Tronina, Rafał Krygier, Witold Dobracki, Iwona Buczyńska, Krzysztof A. Simon, Dorota Dybowska, Waldemar Halota, Małgorzata Pawłowska, Jolanta Citko, Łukasz Laurans, Włodzimierz Mazur, Ewa Janczewska, Łukasz Socha, Zbigniew Deroń, Hanna Berak, Robert Flisiak
Publikováno v:
Archives of Medical Science, Vol 18, Iss 6, Pp 1460-1466 (2019)
Introduction Non-cirrhotic treatment-naive hepatitis C patients infected with genotype 1 can be treated with ledipasvir/sofosbuvir (LDV/SOF) for 8 weeks, but in practice this regimen is frequently extended up to 12 weeks at least in part due to insuf
Externí odkaz:
https://doaj.org/article/98c74331a41c48fab58d3002fa6f0ffa
Autor:
Paweł Rajewski, Dorota Zarębska-Michaluk, Ewa Janczewska, Andrzej Gietka, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Teresa Belica-Wdowik, Barbara Baka-Ćwierz, Dorota Dybowska, Waldemar Halota, Beata Lorenc, Marek Sitko, Aleksander Garlicki, Hanna Berak, Andrzej Horban, Iwona Orłowska, Krzysztof Simon, Łukasz Socha, Marta Wawrzynowicz-Syczewska, Jerzy Jaroszewicz, Zbigniew Deroń, Agnieszka Czauż-Andrzejuk, Jolanta Citko, Rafał Krygier, Anna Piekarska, Łukasz Laurans, Witold Dobracki, Jolanta Białkowska, Olga Tronina, Magdalena Wietlicka-Piszcz, Małgorzata Pawłowska, Robert Flisiak
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 2, p 379 (2022)
HCV infection is one of the main reasons for liver cirrhosis and hepatocellular carcinoma. In recent years, one finds more and more extrahepatic manifestations of HCV infection, including its possible influence on the development of diabetes. In the
Externí odkaz:
https://doaj.org/article/1721d04b79ce47e7b4c7f0dca548abe9
Autor:
Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, Małgorzata Pawłowska, Ewa Janczewska, Hanna Berak, Justyna Janocha-Litwin, Jakub Klapaczyński, Krzysztof Tomasiewicz, Anna Piekarska, Rafał Krygier, Jolanta Citko, Olga Tronina, Krystyna Dobrowolska, Robert Flisiak
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 2, p 389 (2022)
The introduction of the direct-acting antivirals (DAA) has substantially improved the effectiveness of the therapy in patients with chronic hepatitis C. We aimed to compare the efficacy of pangenotypic and genotype-specific DAA in the cohort of genot
Externí odkaz:
https://doaj.org/article/66bd8dee6f44453ea5b5d126aeaac705
Autor:
Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Anna Parfieniuk-Kowerda, Ewa Janczewska, Dorota Dybowska, Małgorzata Pawłowska, Waldemar Halota, Włodzimierz Mazur, Beata Lorenc, Justyna Janocha-Litwin, Krzysztof Simon, Anna Piekarska, Hanna Berak, Jakub Klapaczyński, Piotr Stępień, Barbara Sobala-Szczygieł, Jolanta Citko, Łukasz Socha, Magdalena Tudrujek-Zdunek, Krzysztof Tomasiewicz, Marek Sitko, Beata Dobracka, Rafał Krygier, Jolanta Białkowska-Warzecha, Łukasz Laurans, Robert Flisiak
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 15, p 3280 (2021)
There is still limited data available from real-world experience studies on the pangenotypic regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis. The current study aimed to evaluate the efficacy and safety
Externí odkaz:
https://doaj.org/article/95b8d74b90cf4019ac8ed54f0598a2e8
Autor:
Dorota Zarębska-Michaluk, Michał Brzdęk, Jerzy Jaroszewicz, Magdalena Tudrujek-Zdunek, Beata Lorenc, Jakub Klapaczyński, Włodzimierz Mazur, Adam Kazek, Marek Sitko, Hanna Berak, Justyna Janocha-Litwin, Dorota Dybowska, Łukasz Supronowicz, Rafał Krygier, Jolanta Citko, Anna Piekarska, Robert Flisiak
Publikováno v:
World journal of gastroenterology. 28(45)
The revolution in treatment of patients with chronic hepatitis C virus (HCV) infection dates back to the introduction of direct-acting antivirals (DAAs). The increase in efficacy was most pronounced in patients infected with genotype (GT) 1b, as this
Autor:
Zbigniew Deroń, Łukasz Laurans, Krzysztof Simon, Rafał Krygier, Jolanta Białkowska-Warzecha, Jolanta Citko, Ewa Janczewska, Dorota Dybowska, Beata Dobracka, Jerzy Jaroszewicz, Iwona Buczyńska, Małgorzata Pawłowska, Olga Tronina, Marek Sitko, Brygida Adamek, Anna Piekarska, Krzysztof Tomasiewicz, Beata Lorenc, Magdalena Tudrujek-Zdunek, Łukasz Socha, Robert Flisiak, Agnieszka Czauż-Andrzejuk, Włodzimierz Mazur, Dorota Zarębska-Michaluk, Mateusz Franciszek Kołek, Jakub Klapaczyński, Waldemar Halota, Hanna Berak
Publikováno v:
World Journal of Gastroenterology
Background The introduction of direct-acting antiviral drugs into clinical practice has revolutionized the treatment of chronic hepatitis C, making it highly effective and safe for patients. However, few researchers have analyzed the factors causing
Autor:
Dorota Dybowska, Maciej Piasecki, Beata Lorenc, Łukasz Laurans, Agnieszka Czauż-Andrzejuk, Krzysztof Simon, Magdalena Tudrujek-Zdunek, Jolanta Citko, Włodzimierz Mazur, Rafał Krygier, Ewa Janczewska, Jakub Klapaczyński, Hanna Berak, Łukasz Socha, Marek Sitko, Waldemar Halota, Iwona Buczyńska, Małgorzata Pawłowska, Jolanta Białkowska, Anna Piekarska, Katarzyna Paluch, Olga Tronina, Jerzy Jaroszewicz, Beata Dobracka, Dorota Zarębska-Michaluk, Krzysztof Tomasiewicz, Robert Flisiak, Zbigniew Deroń
Publikováno v:
Expert Review of Anti-infective Therapy. 18:1045-1054
The aim of the study was to analyze the prevalence and clinical characteristics of HCV/HBV coinfection and to evaluate the rate of HBV-reactivation during anti-HCV therapy in a large real-world study.Analyzed population consisted of 10,152 chronic he